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introduction: The purpose of this study is to verify the possible benefit of a clinical data 
warehouse (DWH) for retrospective analysis in the field of radiation oncology.
Material and methods: We manually and electronically (using DWH) evaluated demo-
graphic, radiotherapy, and outcome data from 251 meningioma patients, who were 
irradiated from January 2002 to January 2015 at the Department of Radiation Oncology 
of the Erlangen University Hospital. Furthermore, we linked the Oncology Information 
System (OIS) MOSAIQ® to the DWH in order to gain access to irradiation data. We 
compared the manual and electronic data retrieval method in terms of congruence of 
data, corresponding time, and personal requirements (physician, physicist, scientific 
associate).
results: The electronically supported data retrieval (DWH) showed an average of 93.9% 
correct data and significantly (p = 0.009) better result compared to manual data retrieval 
(91.2%). Utilizing a DWH enables the user to replace large amounts of manual activities 
(668 h), offers the ability to significantly reduce data collection time and labor demand 
(35 h), while simultaneously improving data quality. In our case, work time for manually 
data retrieval was 637 h for the scientific assistant, 26 h for the medical physicist, and 
5 h for the physician (total 668 h).
conclusion: Our study shows that a DWH is particularly useful for retrospective analysis 
in the radiation oncology field. Routine clinical data for a large patient group can be 
provided ready for analysis to the scientist and data collection time can be significantly 
reduced. Furthermore, linking multiple data sources in a DWH offers the ability to improve 
data quality for retrospective analysis, and future research can be simplified.
Keywords: clinical data warehouse, MOsaiQ®, routine clinical data, secondary use of data, data retrieval, 
stereotactic radiotherapy, meningioma
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inTrODUcTiOn
Routinely documented clinical data are of great importance for 
patient care as well as for research purposes (1, 2).
So far, the retrospective analyses in medical research have 
been predominantly performed manually, meaning that clinical 
data are often transferred by hand from routine clinical reports 
into a separate research database (3) and stored in standard 
office tools (e.g., Microsoft Excel spreadsheets), which are not 
validated for clinical research. The continuously increasing 
expansion of electronic documentation in the clinical treatment 
process creates a large amount of various databases (4); thus, 
manual retrospective analysis is currently quite ambitious and 
time consuming.
In the field of radiation oncology, data sets are large and het-
erogeneous (5). Electronic information systems contain patients’ 
data for imaging in the Radiology Information System and Picture 
Archiving and Communication System, for irradiation in the 
Clinical Information System (CIS), e.g., Oncology Information 
System (OIS, MOSAIQ®) and data of the current course of 
the patients’ disease in the electronic health record (EHR, e.g., 
Soarian® Clinicals).
With the increasing amount of patient information captured 
in EHRs and CISs, more opportunities should be established 
to facilitate clinical research by obtaining routine clinical 
data from distributed databases for secondary use, though 
providing access to routine clinical data for secondary use 
is challenging in practice (6). One of the greatest challenges 
in clinical research is to define and implement health data 
standards for integration between routinely used subsystems 
(7, 8). Medical data are frequently distributed across multiple 
electronical information systems of several departments in 
different forms of documentation styles (9). Although most 
university hospitals already implemented commercial hospital 
information systems and started to develop comprehensive 
EHRs, there is still a gap between clinical care and using 
this data for medical research that needs to be filled (10, 11). 
Recent studies have focused on providing routine clinical data 
for research purposes, e.g., by using a single-source tumor 
documentation or supporting systems for patient recruitment 
into clinical trials in the field of radiation oncology (12) and 
intensive care (13).
Data warehouses (DWHs) are central repositories of inte-
grated data from one or more disparate sources. They store 
current and historical data and are used for creating analytical 
reports for knowledge workers throughout the enterprise (14). 
The purpose of this study is to verify the possible benefit of a 
DWH for retrospective analysis and reflect differences in manual 
and automated data retrieval.
Using meningioma patients as an example, we performed a 
therapy evaluation by utilizing an integrated electronic research 
database system DWH (clinical DWH) of the Erlangen University 
Hospital (UKER) to make routine radiotherapy data available 
from various operational subsystems. This is one of the largest 
populations of meningioma patients treated with stereotactic 
radiotherapy (SRT) in a single institution with a comprehensive 
database due to a high overall survival rate and a long observation 
period of meningioma patients after SRT.1
We manually and electronically collected basic information 
(patient characteristics), radiotherapy, and outcome data of 251 
meningioma patients, who were irradiated from January 2002 
to January 2015 at the Department of Radiation Oncology of 
the UKER (see text footnote 1). Currently, manual data collec-
tion represents the “gold standard.” In our study, we compared 
the results of both the electronic and manual data retrieval 
process and determined the congruence of data. Moreover, 
we measured the corresponding time requirements for both 
retrieval methods and the involvement of personnel (physician, 
physicist, scientific associate).
MaTerials anD MeThODs
environment
Erlangen University Hospital (UKER) is a tertiary care hospital 
that has 1.368 beds and combines 24 departments, 18 independent 
divisions, 7 institutes, and 25 interdisciplinary centers. In 2015, 
over 60,000 inpatient and nearly 475,000 outpatient cases were 
treated (15). At the Department of Radiation Oncology, 130–150 
patients with many different tumor entities are irradiated daily. 
Approximately, 32 patients with meningioma are irradiated 
annually.
For our study, an agreement for the usage of routine clinical 
data was signed by those departments of the UKER that were 
involved in the patients’ treatment (Neurosurgery, Neurology, 
Neuropathology, and Radiology). These regulatory requirements 
and institutional policies need to be reconciled to use clinical 
routine data for clinical research activities.
Principles of radiotherapy of intracranial 
Meningioma
During the past two decades, SRT has become increasingly well 
known as a treatment option for meningiomas (16, 17). Adjuvant 
SRT is offered to all grades II and III meningioma patients, 
whereas symptomatic grade I meningioma patients only received 
SRT after incomplete resection. Inoperable grade I (symptomatic 
only), grades II and III meningioma are treated with primary 
SRT. SRT was performed using the stereotactic radiosurgery 
system Novalis™ (BrainLAB, Feldkirchen, Germany). Patients 
were treated on consecutive workdays, with one fraction per day 
(see text footnote 1). SRT was mostly given in 28, 30, or 25 frac-
tions to a median reference dose of 54.0 Gy.
scientific Objective of the retrospective 
analysis
Based on the example of 251 patients with 275 intracranial 
meningiomas treated between January 2002 and January 2015 
1 Lubgan D, Rutzner S, Semrau S, Lambrecht U, Roessler K, Buchfelder M, et al. 
Effective long-term local results and prognostic factors after fractionated stereo-
tactic radiotherapy of 257 intracranial meningeoma. J Neuro Oncol (submitted for 
publication). 
TaBle 1 | summary of clinical information systems (ciss) for manual data retrieval to evaluate routine medical data for retrospective analysis of 
patients with meningioma treated with stereotactic radiotherapy.
clinical application Data source Description
SAP IS-H® Patient administration SAP®-based CIS for patient administration and documentation of diagnosis and procedure 
during the clinical treatment process
Soarian Clinicals® Electronic health record Web-based clinical workstation that offers health information in a digital form
Web-RIS® Imaging Web-based CIS that offers medical, administrative, and imaging data in the field of radiology
GTDS® Medical record for tumor documentation Supports clinical cancer registry and provides information about medical treatment and 
follow-up
MOSAIQ® Radiation Oncology Oncology information system for radiation treatment and the control of the respective linear 
accelerator. It is integrated with imaging, planning, and therapy systems and contains the 
planned and actual dispense treatment parameters
Pinnacle3® Radiation Oncology Treatment planning software for localization of tumor volumes and verification of the individual 
radiation treatment plan
I-Plan RT® Radiation Oncology Treatment planning software for localization of tumor volumes and verification of the individual 
radiation treatment plan
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with SRT at the department of Radiation Oncology of the UKER, 
we have illustrated the workflow of manual and electronical 
supported data retrieval for this analysis. For determination of 
efficacy of SRT on long-term outcome (e.g., overall survival, local 
control), the relevant parameters (age, gender, tumor localiza-
tion, WHO grading, and current disorders after radiotherapy), 
data of the computed tomography (CT) or magnetic resonance 
(MR) imaging (to determine the tumor status after therapy), and 
temporal dose distribution [fractionation, target volume (PTV), 
dose distribution of risk organs] were evaluated.
Workflow of Manual and electronical 
supported Data collection for 
retrospective analysis
Manual Data Retrieval
For the purpose of retrospective analysis, the Department of 
Radiation Oncology begins with specifying the research question 
and defining the patient collective. Here, the patient collective 
was identified by multiple reference sources (e.g., outdated medi-
cal records and databases, institutional statistics) and manually 
summarized in a separate chart (Microsoft Excel 2010). All 
medical data in the routine CISs and necessary data elements for 
each patient were manually and separately noted in an electronic 
document using Microsoft Excel 2010. The systems used for 
manual analysis are listed in Table 1.
To evaluate the time required for manual data retrieval, we 
documented the time needed to collect all necessary data ele-
ments from clinical source systems and manually transcribed 
them into an Excel spreadsheet.
electronically supported Data retrieval
In order to simplify retrospective analysis, we decided to use 
a tool that obtains routine clinical data from multiple CISs 
for secondary use. Since 2003, the UKER provides the clinical 
DWH research platform to scientists for numerous analyses. 
It has the ability to combine data from multiple clinical source 
systems and to provide it to the hospital users. The DWH stores 
clinical and administrative data from 22 different data sources 
(e.g. Accounting, Pharmacy, Surgery, Anesthesia, Pathology, and 
Radiology). For transformation of routine clinical data, it utilizes 
the open enterprise-class platform Cognos Data Manager. The 
database language Structured Query Language (SQL) is used for 
defining data structures, editing, and querying the databases.
We used the DWH for defining a patient collective and 
obtaining routine clinical data from multiple CISs. The workflow 
of manual and electronical supported data retrieval for retrospec-
tive analysis is illustrated in Figure 1.
A database query based on routine clinical data from patient 
care was initiated to design a core data set for retrospective analy-
sis (date of the last contact, date of the last imaging, life-status, 
beginning and end of the radiotherapy, fractionation, and dose). 
Selected data elements and the related data source system are 
shown in Table 2.
The official system which was used for coding of the diag-
nosis is the 10th Revision of German Modification of the Inter-
national  Statistical Classification of Diseases (ICD-10) and for 
procedures the German “Operationen- und Prozedurenschlüssel 
Version 2015.”
Currently, not all listed data elements or source systems are 
accessible for the DWH (e.g., tumor as cause of death in the 
GDTS, the minimum or maximum dose, PTV-volume, cover-
age PTV, dose distribution on risk organs documented in the 
treatment planning software) or there were no suitable methods 
available for the extraction of the data elements (e.g., tumor 
localization, WHO grading, or several radiotherapy documented 
in Soarian® Clinicals) at the time of analysis (Table 2). Therefore, 
they are not included in the electronical analysis.
integrating Ois MOsaiQ® into the clinical 
DWh of the UKer: reusing Data from the 
Ois MOsaiQ® for retrospective analysis
Since 2012, the Department of Radiation Oncology uses the 
OIS MOSAIQ® developed by Elekta (Hamburg, Deutschland). 
It provides medical oncology data (e.g., demographic data, 
FigUre 1 | Workflow of manually and electronically [data warehouse (DWh)] supported data retrieval for retrospective analysis.
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diagnoses, beginning and end of the radiotherapy, planned and 
administered fractionation and doses), regulates the respective 
linear accelerator, and is linked to imaging, planning, and therapy 
systems.
In order to make irradiation data available for retrospective 
analysis, we analyzed the table structure from the clinical system 
and transferred a copy of relevant data tables as read-only user 
during the non-productive clinical stage of radiotherapy (after 
5 p.m.) into the staging area of the DWH. This process is called 
“extraction.” As a next step, we queried the DWH to select patients 
with a diagnosis of meningioma (ICD10-GM code D32.0, D32.9, 
C70.0, C70.9) and to identify the data elements beginning and end 
of the radiotherapy, planned and administered fractionation and 
dose distribution. Subsequently, we compared the results of the 
data base query and the manual data retrieval.
In addition, unnecessary or inconsistent data can be cor-
rected or extinguished at the staging area. This process is called 
“transformation.” The entire process is called ETL (extraction, 
transformation, loading) (18). The structure of the DWH and 
technical implementation of the clinical source system MOSAIQ® 
is illustrated in Figure 2.
statistical analysis and ethics 
committee Vote
Standard summary statistics and two-tailed 95% confidence 
intervals were calculated as appropriate. All statistical analyses 
were performed using the Statistical Package for the Social 
Sciences version 21 (IBM Corp., Armonk, NY, USA). The level 
of significance for all analyses was set at α = 0.05 (two-tailed).
Our institution obtained a positive ethics commit-
tee vote from the ethical review board for our research 
(reference number 347_16 Bc). All data used for the retrospective 
analysis was in anonymized form.
resUlTs
effectiveness of Patient Data  
collection—DWh
A total amount of 275 data sets (case ID) from 251 (patients ID) 
patients were manually collected and stored in a Microsoft Excel 
spreadsheet. We counted 275 data sets (case ID) due to the fact 
that some patients had more than one lesion and thus were irradi-
ated at multiple times.
Two hundred seventy-four electronic data sets (100%) from 
250 patients were electronically collected because one patients’ 
data were not available for data protection reasons. The data 
congruence of the data elements “beginning and end of the 
radiotherapy, date of the last contact, date of the last imaging and 
life-status (alive, dead),” were evaluated on the basis of manual 
data retrieval compared with the results of the DWH report.
Manual Data retrieval compared with the 
results of the DWh report
The summary of selected data elements determined by manual 
and electronical supported data retrieval is shown in Table 3.
Data element “Beginning of the 
radiotherapy” and “end of radiotherapy”
Two hundred fifty-two (92.0%) for manual and 257 (93.8%) for 
the electronical method out of 274 (100%) data elements “begin-
ning of the radiotherapy” and “end of the radiotherapy” were 
TaBle 2 | Overview of selected data elements and the related data source system for retrospective analysis.
Data element Description Data type Data source
Beginning of radiotherapy First day of radiotherapy Date [TT.MM.JJJJ] SAP IS-H®
End of radiotherapy Last day of radiotherapy Date [TT.MM.JJJJ] SAP IS-H®
Beginning of radiotherapy First day of radiotherapy Date [TT.MM.JJJJ] MOSAIQ®
End of radiotherapy Last day of radiotherapy Date [TT.MM.JJJJ] MOSAIQ®
Fractionation Distribution of the total dose in separate doses Numeric MOSAIQ®
Dose Dose value in Gy Numeric [Gy] MOSAIQ®
Date of last contact Date of last contact/treatment at the Erlangen University 
Hospital (UKER)
Date [TT.MM.JJJJ] SAP IS-H®
Date of the last imaging Date of the last computed or magnetic resonance tomography 
of the brain
Date [TT.MM.JJJJ] SAP IS-H®
Life-status Date of death Date [TT.MM.JJJJ] Soarian Clinicals®
Actual patient contact detailsa Master data of a patient (street, house number, postcode, and 
place of residence)
Free text SAP IS-H®
Death due to tumora Death caused by tumor Coded GTDS®
1 = yes
2 = no
999 = cannot be determined
Tumor localizationa Localization of the tumor in the brain Coded Soarian Clinicals®
1 = skull base Web-RIS®
2 = falx
3 = convexity
4 = meningeomatosis
Histology/pathologya Resection of the tumor enables the classification of the  
WHO-Grade (I,II,III)
Coded Soarian Clinicals®
1 = WHO I
2 = WHO II
3 = WHO III
999 = cannot be determined
Previous radiotherapya Preceding radiation on the tumor area Coded Soarian Clinicals®
1 = yes SAP IS-H®
2 = no
Minimum/maximum dosea Lowermost or paramount dose at radiation volume Numeric [Gy] i-Plan RT®, Pinnacle3®
PTV – volumea Size of the planning target volume in cm3 Numeric [Gy] i-Plan RT®, Pinnacle3®
Coverage PTVa Proportion of the target volume within the reference isodose Numeric [Gy] i-Plan RT®, Pinnacle3®
Dose distribution on risk organsa Tolerance dose on the critical organs (opticus right/left, chiasm, 
hippocampus)
Numeric [Gy] i-Plan RT®, Pinnacle3®
aNot included in the electronical [data warehouse (DWH)] analysis (currently not all listed data elements are accessible for the DWH or there were no suitable methods available for 
the extraction of the data elements).
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identical. Thirty-nine (22 manual, 17 electronical) data elements 
were not identical.
Deviating results are more often generated by the manual than 
the electronical data retrieval method. Manual data retrieval pro-
duced 22/274 (8%) deviating results: this difference was caused 
by the fact that in 22 cases the treatment date of radiation was 
incorrectly documented in the discharge letter and the incorrect 
dates were transferred into the Microsoft Excel spreadsheet.
The DWH determined the correct treatment date for these 
22 patients. However, the DWH query produced 17/274 (6.2%) 
deviating results due to an error in the data base query. The query 
was carried out patient-based (patients ID) instead of case-based 
(case ID). If a patient (patients ID) was treated multiple times 
over several years (case ID) only the latest “date of beginning 
and the end” was identified. For a flawless determination of the 
treatment (case ID), date the SQL statement of the data base 
query has to be adjusted for future data exports.
Data element “Date of the last imaging”
Of the 274, 248 (90.5%) by manual and 236 (86.1%) by electroni-
cal retrieval data elements were identical.
Differing results are more often generated by the electronical 
(38/274) than the manual (26/274) data retrieval method. Manual 
data retrieval produced 9.5% of inconsistent data: this difference 
TaBle 3 | The comparison of manual data retrieval and the result of the data warehouse report.
Data element Data type Data source  
manual  
correctness  
of the data (%)
Data source 
electronical 
correctness  
of the data (%)
Data source 
MOSAIQ® 
correctness of 
the data (%)
Beginning of radiotherapy = first day of radiotherapy Date [TT.MM.JJJJ] 252/274 (92.0) 257/274 (93.8)
End of radiotherapy = last day of radiotherapy Date [TT.MM.JJJJ] 252/274 (92.0) 257/274 (93.8)
Beginning of radiotherapy = first day of radiotherapy Date [TT.MM.JJJJ] 88/110 (80.0) 110/110 (100)
End of radiotherapy = last day of radiotherapy Date [TT.MM.JJJJ] 88/110 (80.0) 110/110 (100)
Fractionation = distribution of the total dose in separate doses Numeric 70/74 (94.6) 74/74 (100)
Dose = dispense dose value in Gy Numeric [Gy] 70/74 (94.6) 74/74 (100)
Date of the last imaging = date of the last magnetic resonance or 
computed tomography imaging
Date [TT.MM.JJJJ] 248/274 (90.5) 236/274 (86.1)
Date of last contact = date of the last contact/treatment at the UKER Date [TT.MM.JJJJ] 232/274 (84.7) 274/274 (100)
Life-status = date of death Date [TT.MM.JJJJ]  
manual coded
14/14 (100) 7/14 (50.0)
0 = dead
1 = alive
χ2 test data source manual compared to data source electronical (MOSAIQ® included) p = 0.009.
Data are number of data elements (%) unless otherwise stated. p-value: analysis of covariance, χ2 test in case of categorical data.
FigUre 2 | integrating Oncology information system (Ois) MOsaiQ® into the clinical data warehouse (DWh) of the UKer for secondary use: we 
transferred a copy of relevant data tables as read-only user during the non-productive clinical stage of radiotherapy (after 5 p.m.) into the staging area 
of the DWh (extraction). As a next step, we queried the DWH to identify relevant data elements (beginning and end of the radiotherapy, fractionation and dose).
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was caused by the fact that over the course of time of manual data 
retrieval, an additional imaging was performed for 26 patients; 
thus, manually collected data were already outdated.
The DWH report determined 38 cases (13.9%) of diverging 
data: for 38 patients an imaging was performed at an external 
hospital. The information about external imaging is not 
FigUre 3 | The overall workload time of all involved professional 
groups for manually retrospective analysis of patients with 
meningioma treated with stereotactic radiotherapy is about 668 h.
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accessible by a database query as it is based on the documented 
procedure code in the source system of the UKER.
Data element “Date of the last contact”
All data elements collected electronical were identical. Deviating 
results are only caused by the manual (42/274, 15.3%) data 
retrieval method. There were two reasons for this: first, for 18 
patients the date of the last contact was incorrectly transferred 
from the source system into the Excel spreadsheet. Second, dur-
ing the time of analysis, 24 patients were being treated again in 
another department at the UKER, and subsequently, manually 
collected data were already outdated.
Data element “life-status”
Overall 14 (5.6%) of 251 evaluated patients died. For all 14 
patients, the day of death was manually collected. Seven (50.0% 
of all deceased) patients were overlooked by the DWH report 
because no information about their death was documented in the 
EHR (Soarian® Clinicals) as the date of death is only documented 
for patients who died at the UKER.
effectiveness of Patient Data  
collection—Ois
Fractionated SRT is documented in the OIS MOSAIQ® since June 
2012. We identified 110 suitable values for 74 patients (74 ste-
reotactic irradiation + 36 data values for boost irradiation) since 
the system went into operation at the department of Radiation 
Oncology and transferred them into the DWH. We collected the 
data elements “beginning and end of radiotherapy, distributed 
dose and fractionation” by querying the DWH and compared the 
results with the manual data retrieval.
Manual Data retrieval compared with the 
results of the Mosaiq® report
Data Element “Beginning of the Radiotherapy” and 
“End of Radiotherapy”
Differing results were only caused by the manual data collec-
tion method (22/110): due to an incorrect date in the medical 
discharge letter manually retrieved data produced the deviat-
ing data for the beginning of radiotherapy and for the end of 
radiotherapy.
There were no deviating results by querying the source sys-
tem MOSAIQ® (DWH report) because the linear accelerator is 
regulated by the OIS that uses validation rules for data entry for 
every single fractionation in the primary source system.
Data element “administered Dose and 
Fractionation”
In all, 94.6% (70/74) data elements were identical. The manual 
data retrieval methods lead to 4 (5.4%) deviating results 
because a medical physicist determined 4 false data elements 
of administered dose and fractionation on the basis of the 
paper-based health record, OIS MOSAIQ® and the treatment 
planning systems I-plan RT® or Pinnacle3®. There were no 
deviating results by querying the source system MOSAIQ® 
(DWH report).
Time invested in Manual Data retrieval
To evaluate the time required for manual data retrieval, we 
documented the time needed to collect all necessary data 
elements from clinical source systems and manually transmit 
them into a Microsoft Excel spreadsheet. The manual data 
retrieval required 668 h (Figure 3). The collection of all data 
elements took place over an extended period of time of about 
24  weeks.
The scientific assistant required the largest amount of time 
while manually collecting routine clinical data in 637 h (95.4%) 
The support of a physician (5 h, 0.7%) and a medical physicist 
(26 h, 3.9%) was required (Figure 3). The physician analyzed 
actual MR or CT imaging (to determine localization, relapse, 
and progression of the tumor) and the medical physicist 
evaluated necessary data elements (PTV volume, fractiona-
tion, doses, minimum/maximum dose, coverage PTV, dose 
distribution of risk organs) on the basis of the paper-based 
health record and the treatment planning systems I-plan RT® 
or Pinnacle3®.
Time consumption for electronical Data 
retrieval
In collaboration with a computer scientist of the Department 
of Medical Informatics and two scientific assistants of the 
Department of Radiation Oncology of the UKER, the DWH 
report was developed. Implementing the DWH query took 30 h 
that are composed of the definition, adjustment, and execution of 
the database query. For administrative activities (e.g., obtaining 
permission for data access by those departments of the UKER, 
which were involved in the patients’ treatment), we need addi-
tional 5 h.
The support of a medical physicist was not required to evalu-
ate data elements (beginning and end of radiotherapy, admin-
istered fractionation, and dose) on the basis of the paper-based 
health record and the treatment planning systems I-plan RT® 
or Pinnacle3®. For evaluating the data elements (PTV volume, 
minimum/maximum dose, coverage PTV, dose distribution of 
8Rutzner et al. Clinical DWH for Retrospective Analysis
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risk organs), the support of the medical physicist (approximately 
20 h) and a physician (5 h) to analyze actual MR or CT imaging 
is still required.
DiscUssiOn
The purpose of this study is to verify possible benefits of a clinical 
DWH for retrospective analysis in the field of radiation oncology.
We compared two different methods of collecting routine 
clinical data: manually and electronically using DHW for second-
ary use of the scientific retrospective analysis.
In summary, our results indicated that the electronically sup-
ported data retrieval (DWH) showed an average of 93.9% correct 
data and a significantly better (p =  0.009) result compared to 
manual data retrieval (91.2%). Using a research, database (DWH) 
replaces manual activities and offers the ability to significantly 
reduce data collection time and labor while improving data 
quality. However, data integrity depends on the quality of a 
structured routine clinical documentation as well as the system 
requirements to get access to medical data in the clinical source 
systems. Furthermore, expert knowledge for the transformation 
of routine clinical data is necessary in practice.
In our study, manual data retrieval needed significantly 
more overall workload time (668 h) of all involved professional 
groups compared to implementing the DWH query (30 h). We 
needed the support of a physician (5  h) to manually analyze 
CT or MR imaging and a medical physicist (26 h) for evaluat-
ing necessary irradiation data elements (fractionation, dose 
distribution, coverage/PTV volume, minimum/maximum 
dose, dose distribution at risk organs). Up to now, the support 
of a physician (5 h) to analyze actual MR or CT imaging is still 
required. In order to completely automate the assignment of the 
medical physicist for retrospective analysis (evaluating the data 
elements coverage/PTV-volume, minimum/maximum dose, 
dose distribution at risk organs), the departmental planning-
systems I-plan® RT and Pinnacle3® need to be made accessible 
for the DWH.
In addition, the long period of time necessary for retriev-
ing data manually produced outdated databases and caused 
errors when transmitting data into an electronic format such 
as Microsoft Excel, which became evident in some cases of our 
study. Furthermore, data retrieval errors can easily be introduced 
because medical record data are not guaranteed to be accurate 
(e.g., incorrectly documented treatment date of radiation in the 
discharge letter of radiotherapy) and depend on the care and 
knowledge level of the scientific assistant. A related study by 
Roelofs et al. (19) that examined the benefit of a clinical DWH 
combined with tools for extraction of relevant parameters data 
for a radiotherapy trial supports this point of view. A DWH is 
beneficial for data collection time in addition to offering the abil-
ity to improve data quality.
Besides of benefits of data collection times and improving 
data quality, the strength of a DWH its ability to combine 
data from multiple clinical source systems and make it easily 
accessible for researchers. Though, before using routine data for 
research purposes, it is important to carefully verify this data 
and determine data integrity. In this context, Galster (20) has 
reviewed existing barriers for reusing routine data, he came 
to the conclusion that clinical data are not available when or 
where it is needed, even though data is present, the usage of the 
existing source is prohibited or cannot be routinely used in its 
available form. In our study, there are regulatory requirements 
and institutional agreements that need to be reconciled from the 
departments of the UKER that are involved in the patients’ treat-
ment in order to use clinical routine data for clinical research 
activities.
Next to the challenges of gaining access to multiple data 
sources, another major barrier for data reuse is the fact that 
routine data cannot be used in its available form. Usually, 
clinical data are distributed across several tables in a generic 
form with coded values (21). In our analysis, some data (e.g., 
tumor localization, histology/pathology) are semi-structured 
values (mostly free-text format) and therefore can’t be used for 
automatically analysis. The data recorded in structured fields 
are more readily to be extracted from an EHR than data that 
was recorded in free text notes. Therefore, expert knowledge for 
the transformation of this data is necessary, and the accuracy of 
database queries mainly depends on a specific SQL statement. 
In addition, EHR data are frequently recorded inconsistently 
in a variety of formats that are complex, inaccurate, and often 
incomplete (22). For our study, it is a necessary condition that 
medical data are recorded completely in a specific data schema in 
order to automatically capture as much information as possible 
for retrospective analysis.
Furthermore, EHRs often do not tell a complete patient 
story, whether it may be those of a single institution or those 
aggregated across institutions (23). An example for this problem 
in our study is the date of death that is only documented in 
the clinical source system (EHR) for patients who died at the 
UKER. Moreover, the information about an external imaging 
is not routinely documented in a coded form in the EHR and 
is therefore not accessible for database queries. Consequently, 
medical details from external sources (e.g., life status in the 
GTDS®, imaging at an external hospital) must be requested or 
made available for automated data abstraction. This would be 
worthwhile in order to determine a patients’ life status as an 
electronical life-status comparison with the residents’ registra-
tion offices is prohibited due to privacy policy since 2008 and 
an amendment to the Bavarian Cancer Registry is made for 
provision in 2016 (24). To keep the medical routine data up to 
date, we send a specially designed questionnaire to the patients 
in order to assess the health-related outcome that are completed 
by patients themselves.
Additionally, routine clinical documentation in the primary 
source systems affects the research outcome: data quality for 
retrospective analysis is only as good as the routine clinical 
documentation in the primary source systems e.g., EHR. 
Therefore, Kessel et  al. (5) have developed a professional 
data-based documentation system for analysis purposes where 
information about radiation therapy, diagnostic images, and 
dose distributions has been imported into a web-based system. 
They showed that the central storage of data outside of EHR 
leads to benefits of digital management, data analysis, and 
reusability of the results. In this context, Kirrmann et  al. (9) 
TaBle 4 | limitations for using a data warehouse (DWh) for retrospective analysis in the radiation oncology field.
limitations example in our study Potential solution Benefit
Restricted data access • Regulatory requirements and institutional agreements 
need to be reconciled from those departments, which 
were involved in the patients’ treatment
• Amendment of agreement between 
the departments of UKER about using 
clinical routine data for clinical research 
activities
• Data integrity
Variety of data formats • Data cannot be routinely used in its available form: expert 
knowledge for the transformation of this data is necessary
• Implementing data standards for 
the secondary use of health data to 
support clinical research
• Availability of all 
data elements for 
retrospective analysis
Data quality of routine 
clinical documentation
• Medical data generated in the clinical treatment process 
are not guaranteed to be accurate
• Electronic health records often do not tell a complete 
patient story: e.g., life-status (GTDS®), imaging (e.g., 
computed tomography/MRT) at an external hospital
• Using original and unprepared data 
from primary source systems
• Making external source systems (e.g., 
GTDS®) accessible for the DWH
• Request external sources
• Higher data quality
• Data integrity
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developed and described a flexible browser based reporting 
and visualization system for clinical and scientific use by 
linking web-services/MOSAIQ®, the physician letter system 
MEDATEC, and central server MiraPlus (laboratory, pathol-
ogy and radiology). They reported that all relevant data were 
available at all times in a simple manner, which improved 
their effectiveness resulting in a considerable amount of time 
saving.
In this context, one benefit of our retrospective analysis was 
that the gain of access to radiotherapy data from the clinical 
source system MOSAIQ®. Besides the data sets “beginning and 
the end of radiotherapy” for evaluating treatment outcomes 
of patients with meningioma, we also extracted irradiation 
parameters “planned and effectively implemented fractionation 
and dosage distribution” from the existing primary source (OIS). 
Due to the fact that the linear accelerator and the OIS both use 
validation rules for data entry in the primary source system, 
original routine data are not subsequently changed. As we have 
shown in our analysis, using original and unprepared data leads 
to a higher percentage of accurate data.
A summary of described limitations and potential solutions 
using a DWH are shown in Table 4.
Although only a selected data set of the evaluation of patients 
with meningioma was examined and not all data were directly 
available in a DWH, our present study highlights the benefit of 
electronical supported data retrieval for secondary use. Thus, our 
goal is to adapt our approach to other types of tumors in radiation 
oncology and extract more parameters from the existing routine 
care documentation systems.
cOnclUsiOn
Our present study shows that a DWH is particularly beneficial 
for retrospective analysis in the field of radiation oncology. 
Routine clinical data for a large patient group can be provided 
ready for analysis to the scientific operator, and data collection 
time can be reduced significantly. Furthermore, using a DWH 
provides the ability to improve data quality for retrospective 
analysis; thus, future research can be simplified. However, 
expert knowledge for the transformation of routine clinical 
data is still necessary and the quality of a structured routine 
clinical documentation in the CISs as well as the system 
requirements allowing access to medical data also affect the 
outcome.
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